Benzinga | Nov 4, 2021 08:25AM EDT

Entasis Therapeutics Hldg Q3 EPS $(0.26) Beats $(0.30) Estimate

Entasis Therapeutics Hldg (NASDAQ:ETTX) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.30) by 13.33 percent. This is a 29.73 percent increase over losses of $(0.37) per share from the same period last year.